Press Releases Dr. Reddy's Laboratories Limited Nyse

Equities

RDY

US2561352038

Market Closed - Nyse Other stock markets 04:00:02 2024-07-16 pm EDT			5-day change	1st Jan Change
78.47 ^USD	-2.45%		+1.02%	+12.78%

Jul. 16	Asian Equities Traded in the US as American Depositary Receipts Move Modestly Higher in Tuesday Trading	MT
Jul. 16	Indian Equities Achieve New Closing Highs on Tuesday, Led by Realty, FMCG Goods Stocks	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dr Reddy Laboratories : Corporate Governance Report- June 2024	Jul. 16	PU
Dr Reddy Laboratories : ESG Data Reporting Criteria 2024 0	Jul. 11	PU
Dr Reddy Laboratories : ESG Data Reporting Criteria 2024	Jul. 11	PU
Dr Reddy Laboratories : . Reddy's Integrated Annual Report 2023 24	Jul. 02	PU
Dr Reddy Laboratories : . Reddy's BRSR 2023 24	Jul. 02	PU
Dr Reddy Laboratories : . Reddy's - Notice of 40th AGM	Jul. 02	PU
Dr Reddy Laboratories : Familiarization programs FY2024	Jul. 01	PU
Dr Reddy Laboratories : Zydus and Dr. Reddy’s announce licensing agreement for co marketing of Pertuzumab biosimilar, a critical treatment for breast cancer patients in India Form 6 K	Jun. 28	PU
Dr Reddy Laboratories : Press Release Zydus & Dr. Reddy's	Jun. 28	PU
Sub: Audio Recordings of the Investor call conducted on June 26, 2024 Form 6 K	Jun. 28	PU
Haleon strikes £500m deal to sell major business unit	Jun. 27	AQ
Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business	Jun. 26	BU
Dr Reddy Laboratories : . Reddy's to discuss acquisition of global brand Nicotinell® and related brands outside of the U.S. from Haleon plc on June 26th, 2024 Form 6 K	Jun. 26	PU
Dr Reddy Laboratories : Press release - Dr. Reddy's to acquire Nicotinell consumer healthcare	Jun. 26	PU
Industry Update: Dr. Reddy's Growth Trajectory: Breaking Down the Pharma Giant's Record Revenues in FY24	Jun. 13	AQ
Dr Reddy Laboratories : Surveillance of ICRA assigned Credit Rating for Rs. 500.00 crore Bank Facilities and Enhancement of Rs. 700.00 Crores Bank Facilities of Dr. Reddy's Laboratories Limited Form 6 K	Jun. 05	PU
Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing Capabilities	Jun. 03	BU
Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America	May. 28	BU
Alvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK	May. 21	BU
Dr. Reddy’s Q4 & Full Year FY24 Financial Results	May. 07	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Dr. Reddy's Laboratories Limited Nyse

Equities

RDY

US2561352038

Press Releases

Filters